BEACOPP is a chemotherapy regimen for treatment of Hodgkin's lymphoma, consisting of treatment with bleomycin, etoposide, doxorubicin (also called Adriamycin), cyclophosphamide, vincristine (also called Oncovin), procarbazine and prednisone. Patients typically receive treatment in cycles of 21 days, but a more intensive regimen also exists with cycles of 14 days. All drugs are administered intravenously.